NASDAQ:BMRA
Biomerica, Inc Stock News
$0.661
-0.0048 (-0.721%)
At Close: May 20, 2024
Biomerica Reports Fiscal 2023 Year End Results
05:00pm, Friday, 25'th Aug 2023
IRVINE, Calif., Aug. 25, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its fiscal 2023 financial results.
CVS Health to Begin Nationwide In-Store Sales of Biomerica's EZ Detect™ Colorectal Disease Screening Test
08:19am, Thursday, 03'rd Aug 2023
IRVINE, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that CVS Pharmacy has begun in-store sales rollout of the Company's EZ Detect™ co
Biomerica stock leaps as Walmart expands sales of Aware Breast Self Exam to its stores
09:46am, Friday, 14'th Oct 2022
Shares of Biomerica Inc. BMRA, +7.58% shot up 13.1% toward a 6-month high in active morning trading Friday, after the medical diagnostic products company said Walmart Inc. WMT, +0.45% will start selli
Walmart to Start Selling Biomerica's Aware Breast Self Exam Devices
11:59am, Thursday, 14'th Jul 2022
Biomerica Inc (NASDAQ: BMRA) announced that its Aware Breast Self Exam device will now be sold in Walmart Inc's (NYSE: WMT) retail system. The Biomerica FDA-cleared Aware Breast Self Exam devic
Biomerica Posts Encouraging Results From InFoods Study As Irritable Bowel Syndrome Treatment
05:27pm, Tuesday, 08'th Feb 2022 Benzinga
Biomerica Inc (NASDAQ: BMRA ) has announced topline results from its InFoods IBS diagnostic-guided therapy (DGT) endpoint clinical trial. The trial showed statistically significant improvements in multiple endpoints in the Intent-to-Treat population. The InFoods DGT uses a simple blood test to identify patient-specific foods that may alleviate Irritable Bowel Syndrome (IBS) symptoms such as pain, bloating, diarrhea, and constipation when removed from the … Full story available on Benzinga.com
Mycoplasma Test Kit Market is Grabbing New opportunities by Top Key Players - Fujirebio, Inc., Eurolyser Diagnostica, BIOMERICA
09:01am, Friday, 24'th Dec 2021 OpenPR
Mycoplasma Test Kit Market research report conveys a nearby watch on driving contenders with key examination, miniature and full scale market pattern and situations, estimating investigation and a comprehensive outline of the market circumstances in the figure time frame. It
Biomerica, Inc. (NASDAQ:BMRA) Expected to Announce Earnings of -$0.08 Per Share
05:56pm, Thursday, 23'rd Dec 2021 Transcript Daily
Brokerages predict that Biomerica, Inc. (NASDAQ:BMRA) will announce earnings of ($0.08) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Biomericas earnings. Biomerica reported earnings of ($0.13) per share during the same quarter last year, which would indicate a positive year over year growth rate of 38.5%. []
Biomerica Inc. (NASDAQ: BMRA) Down -1.48%: This Is What Analysts Now Expect
02:00pm, Friday, 17'th Dec 2021 Stocks Register
Biomerica Inc. (NASDAQ:BMRA) shares, rose in value on Thursday, 12/16/21, with the stock price down by -1.48% to the previous days close as strong demand from buyers drove the stock to $4.00. Actively observing the price movement in the last trading, the stock closed the session at $4.06, falling within a range of $3.72 and Biomerica Inc. (NASDAQ: BMRA) Down -1.48%: This Is What Analysts Now Expect Read More »
Biomerica Announces Preliminary Second Quarter Revenue Increase of Approximately 238%, to Approximately $4.6 Million
01:19pm, Thursday, 16'th Dec 2021 Intrado Digital Media
IRVINE, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the Company) today announced certain preliminary financial results for the second fiscal quarter ended November 30, 2021. All figures in this release are approximate due to the preliminary nature of this announcement.
Enteric Disease Testing Market Overall Study Report 2021-2028 | Alere, Inc., Becton Dickinson & Company, Biomerica, Inc., bioMerieux, Bio-Rad
12:59pm, Thursday, 25'th Nov 2021 OpenPR
Intestinal infections in enteric diseases can cause a variety of symptoms ranging from asymptomatic to severe, such as vomiting, abdominal cramps, anorexia, and nausea. Extreme symptoms and clinical signs, in some cases, can even result in death due to a
Biomerica Forms Scientific Advisory Board for Colorectal Cancer Screening
01:19pm, Friday, 19'th Nov 2021 Intrado Digital Media
IRVINE, Calif., Nov. 19, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA ) today announced that Dr. Brooks Cash, one the nations most recognized leaders in Gastroenterology medicine, has agreed to chair Biomericas newly formed Colorectal Cancer Scientific Advisory Board (SAB). The SAB will guide and help expand the use of the EZ Detect product in Colorectal Cancer screenings and reaching underserved patient populations. Other key opinion leaders in the Gastroenterology field will be joining Dr. Cash on this SAB.
Recap: Biomerica Q1 Earnings
07:34am, Tuesday, 19'th Oct 2021
Biomerica(NASDAQ:BMRA) stock rose by 2.53% on Monday after the company reported its Q1 earnings results on Friday, October 15, 2021 at 06:30 AM. Here's what investors need to know about the announceme
Walmart to Begin Nationwide In-Store Sales of Biomerica's EZ Detect™ Colorectal Screening Test
06:39am, Tuesday, 19'th Oct 2021
IRVINE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that Walmart has begun in-store sales and rollout of the Company's EZ Detect™ col
Biomerica Reports Results for Fiscal First Quarter ended August 31, 2021
06:39am, Friday, 15'th Oct 2021
IRVINE, Calif., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its first quarter fiscal 2022 finan
BMRA Stock: Why It Increased Drastically Today
02:25pm, Tuesday, 05'th Oct 2021
The stock price of Biomerica, Inc. (NASDAQ: BMRA) increased by over 19% during intraday trading today. This is why it happened.